EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lysophosphatidic Acid Receptor Signaling in the Human Breast Cancer Tumor Microenvironment Elicits Receptor-Dependent Effects on Tumor Progression

Matthew G K Benesch iD, Rongrong Wu iD, Xiaoyun Tang, David N Brindley iD, Takashi Ishikawa, Kazuaki Takabe iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24129812 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Matthew G K Benesch und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA. Hauptthemen laut MEDLINE: Receptors, Lysophosphatidic Acid, Breast Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, USA, US Department of Defense BCRP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysophosphatidic acid receptors (LPARs) are six G-protein-coupled receptors that mediate LPA signaling to promote tumorigenesis and therapy resistance in many cancer subtypes, including breast cancer. Individual-receptor-targeted monotherapies are under investigation, but receptor agonism or antagonism effects within the tumor microenvironment following treatment are minimally understood. In this study, we used three large, independent breast cancer patient cohorts (TCGA, METABRIC, and GSE96058) and single-cell RNA-sequencing data to show that increased tumor LPAR1, LPAR4, and LPAR6 expression correlated with a less aggressive phenotype, while high LPAR2 expression was particularly associated with increased tumor grade and mutational burden and decreased survival. Through gene set enrichment analysis, it was determined that cell cycling pathways were enriched in tumors with low LPAR1, LPAR4, and LPAR6 expression and high LPAR2 expression. LPAR levels were lower in tumors over normal breast tissue for LPAR1, LPAR3, LPAR4, and LPAR6, while the opposite was observed for LPAR2 and LPAR5. LPAR1 and LPAR4 were highest in cancer-associated fibroblasts, while LPAR6 was highest in endothelial cells, and LPAR2 was highest in cancer epithelial cells. Tumors high in LPAR5 and LPAR6 had the highest cytolytic activity scores, indicating decreased immune system evasion. Overall, our findings suggest that potential compensatory signaling via competing receptors must be considered in LPAR inhibitor therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Lysophosphatidic AcidBreast NeoplasmsHumansFemaleTumor MicroenvironmentEndothelial CellsSignal TransductionLysophospholipids

Stichwörter der Autor:innen

autotaxinbioinformaticslysophosphatidatenovel therapeuticssignal transductiontumor progression

Substanzen

Receptors, Lysophosphatidic AcidLysophospholipidsLPAR5 protein, humanLPAR6 protein, human

Autor:innen und Institutionen

  • Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Department of Breast Surgery and Oncology, Tokyo Medical University, Tokyo 160-8402, Japan.
  • Cancer Research Institute of Northern Alberta, Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada.
  • Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
  • Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8520, Japan.
  • Department of Breast Surgery, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.

ORCID-Profile: Matthew G K Benesch, Rongrong Wu, David N Brindley, Kazuaki Takabe

Förderung

  • NCI NIH HHS
  • National Institutes of Health, USA
  • US Department of Defense BCRP
  • National Cancer Institute Cancer Center Support Grant

Zitieren

APA

Benesch, M. G. K., Wu, R., Tang, X., Brindley, D. N., Ishikawa, T., & Takabe, K. (2023). Lysophosphatidic Acid Receptor Signaling in the Human Breast Cancer Tumor Microenvironment Elicits Receptor-Dependent Effects on Tumor Progression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24129812

Vancouver

Benesch MGK, Wu R, Tang X, Brindley DN, Ishikawa T, Takabe K. Lysophosphatidic Acid Receptor Signaling in the Human Breast Cancer Tumor Microenvironment Elicits Receptor-Dependent Effects on Tumor Progression. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24129812

BibTeX
@article{Benesch2023,
  author = {Benesch, Matthew G K and Wu, Rongrong and Tang, Xiaoyun and Brindley, David N and Ishikawa, Takashi and Takabe, Kazuaki},
  title = {Lysophosphatidic Acid Receptor Signaling in the Human Breast Cancer Tumor Microenvironment Elicits Receptor-Dependent Effects on Tumor Progression},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24129812}
}
Kostenlos starten →